ArticleParasites & vectors2026
Programmatic implementation of Ovicol ovitraps for Aedes spp. control in Colombia: operational adherence, effectiveness and comparisons with AGO and BG-Sentinel traps.
Article in Parasites & vectors, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
backgroundThe global expansion of Aedes aegypti and Aedes albopictus mosquitoes has intensified arboviral epidemics, generating annual socio-economic losses exceeding 2 billion US dollars, mainly in the Americas. The desiccation-resistant egg stage plays a key role in mosquito persistence and spread, yet this developmental stage remains insufficiently targeted by current control strategies. In this context, the objective of this study was to evaluate the operational feasibility and effectiveness of a low-cost, handcrafted ovitrap (Ovicol) using two types of bioattractants, implemented by two territorial health entities (Entidades Territoriales de Salud [ETSs]) in Colombia, and to compare its performance with that of industrial autocidal gravid ovitraps (AGO) and BG-Sentinel (BGS) traps
methodsOvicol traps were baited with bird seed or molasses + yeast bioattractants. In Santa Marta, traps were installed in public areas (markets, cemeteries, sports complexes) using diflubenzuron as insecticide; in San José del Guaviare, the traps were deployed in buildings (hotels, schools, health centers) using a combination of diflubenzuron and Bacillus thuringiensis israelensis (BTi) as insecticide treatment. Data were analyzed through descriptive statistics, analysis of variance/chi-square test, nonparametric tests and spatial cluster detection.
resultsIn Santa Marta, 41,677 eggs (100% Ae. aegypti) were eliminated and inactivated in 5 weeks. The Oviposition Positivity Index (OPI) ranged from 40.6% to 74.5%, with up to 88% of traps lost to the study at one site due to vandalism. In Guaviare, Ovicol traps registered oviposition within 24 h and outperformed AGO in terms of Aedes detection (65.2% vs. 30.8%, respectively; r = 0.87; P < 0.001). The fermented bird seed attractant achieved higher positivity (Kruskal-Wallis H = 9.42; P = 0.009). Compared with BGS traps, Ovicol showed superior stability in the field, with BGS traps limited by ≥ 70% rate of electrical disconnection during weekends, and low concordance (kappa: - 0.17).
conclusionsOvicol is a cost-effective, operationally simple, and eco-sustainable tool for Aedes surveillance and control. By outperforming AGO and complementing BGS traps, Ovicol enhances spatiotemporal resolution for early microfocus detection and targeted response. Acting as a lethal trap, one diflubenzuron tablet (normally for 200 l) can treat approximately 800 Ovicol (0.25 L each), extending coverage to approximately 800 households and achieving an approximately 800-fold increase in larvicide efficiency. These findings support Ovicol's incorporation into national programs to promote sustainable, community-driven integrated vector management.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.